Filtered By:
Drug: Methotrexate

This page shows you your search results in order of relevance. This is page number 14.

Order by Relevance | Date

Total 6619 results found since Jan 2013.

< em > HLA-G < /em > 3'UTR polymorphisms & amp; response to a yoga-based lifestyle intervention in rheumatoid arthritis: A randomized controlled trial
CONCLUSIONS: Yoga intervention results in improvement and reduced severity of RA in patients irrespective of the HLA-G 14 bp ins/del or +3142G>C polymorphisms. YBLI may be used as an adjunct therapy in RA independent of the genotypes.PMID:35859388 | DOI:10.4103/ijmr.IJMR_3196_20
Source: The Indian Journal of Medical Research - July 21, 2022 Category: Biomedical Science Authors: Surabhi Gautam Uma Kumar Richa Mishra Rima Dada Source Type: research

Treatment Guidelines in Rheumatoid Arthritis
Rheum Dis Clin North Am. 2022 Aug;48(3):679-689. doi: 10.1016/j.rdc.2022.03.005. Epub 2022 Jul 5.ABSTRACTRheumatoid arthritis is the most common autoimmune, destructive, inflammatory arthritis in adults. Effective treatments include oral conventional synthetic disease-modifying antirheumatic drugs (DMARDs; eg, methotrexate), injectable biologic DMARDs, and targeted synthetic DMARDs (oral). Key recommendations are to start effective treatment immediately with DMARDs to reduce disability; use effective doses of methotrexate (oral or subcutaneous) with folic acid as the initial treatment; rapidly escalate treatment with vario...
Source: The Medical Clinics of North America - August 11, 2022 Category: General Medicine Authors: Jasvinder A Singh Source Type: research

< em > HLA-G < /em > 3'UTR polymorphisms & amp; response to a yoga-based lifestyle intervention in rheumatoid arthritis: A randomized controlled trial
CONCLUSIONS: Yoga intervention results in improvement and reduced severity of RA in patients irrespective of the HLA-G 14 bp ins/del or +3142G>C polymorphisms. YBLI may be used as an adjunct therapy in RA independent of the genotypes.PMID:35946202 | DOI:10.4103/ijmr.IJMR_3196_20
Source: The Indian Journal of Medical Research - August 10, 2022 Category: Biomedical Science Authors: Surabhi Gautam Uma Kumar Richa Mishra Rima Dada Source Type: research

Treatment Guidelines in Rheumatoid Arthritis
Rheum Dis Clin North Am. 2022 Aug;48(3):679-689. doi: 10.1016/j.rdc.2022.03.005. Epub 2022 Jul 5.ABSTRACTRheumatoid arthritis is the most common autoimmune, destructive, inflammatory arthritis in adults. Effective treatments include oral conventional synthetic disease-modifying antirheumatic drugs (DMARDs; eg, methotrexate), injectable biologic DMARDs, and targeted synthetic DMARDs (oral). Key recommendations are to start effective treatment immediately with DMARDs to reduce disability; use effective doses of methotrexate (oral or subcutaneous) with folic acid as the initial treatment; rapidly escalate treatment with vario...
Source: The Medical Clinics of North America - August 11, 2022 Category: General Medicine Authors: Jasvinder A Singh Source Type: research